Nieuws Wet & Recht Hulpverleners Markt Onderzoek Spierziekten Webwinkel Links Hulpmiddelen Vereniging Mijn VSN Normale lettergrootte Grote lettergrootte Grootste lettergrootte
VSN - Vereniging met veel gezichten
HomeWord lid E-mail Myocafé
   Vereniging Spierziekten Nederland
deze site internet

sitemap: Sitemap lettergrootte: Lettergrootte

Momenteel online:
57 bezoekers
    < Home < Spierziekten < Guillain-Barré syndroom

Guillain-Barré syndroom

Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndroom
Koga M. e.a.
Neurology 2003 (60) blz. 1514

Differential distribution of HLA-DQb/DRb epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQb epitopes associated with susceptibility to and p
Magira EE e.a.
Cochrane Database of Systematic Reviews 2003 (170) blz. 3074

Connecting impairment, disability, and handicap in immune mediated polyneuropathies.
Merkies ISJ, Schmitz PIM, van der Meché FGA, Samijn JPA, van Doorn PA.
Journal of Neurology, Neurosurgery, and Psychiatry 2003 (74) blz. 99

Diagnosis and treatment of enteric neuromuscular diseases
Camilleri M.
Clinical Autonomic Research 2003 (13) blz. 10-15

Practice parameter: immunotherapy for Guillain-Barré syndrome.
R.A.C. Hughes e.a.
Neurology 2003 (61) blz. 736

Activation of latent myostatin by the BMP1/tolloid family of metalloproteinases
Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ.
Proceedings of the National Academy of Sciences of the United States of America 2003 (100) blz. 15842

A randomized controlled trial of recombinant interferon-beta 1a in Guillian-Barré syndrome.
J. Pritchard e.a.
Neurology 2003 (61) blz. 1282

Outcome of axonal and demyelinating forms of Guillain-Barré syndrome in children
H. Tekgul e.a.
Pediatric Neurology 2003 (28) blz. 295

VSN - Lt. gen. van Heutszlaan 6 - 3743 JN Baarn tel: 035-5480480
e-mail: - Bank: ING 1422400

disclaimer - colofon